• Provider Login
  • Payors
  • Manufacturers
  • Blog
  • Careers
Avella Specialty Pharmacy
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact
Menu
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact

Specialty Pharmacy Insights

Return to blog

Are You at Risk for Hepatitis?

Posted by Avella Specialty Pharmacy on Wed, Nov 6, 2013
  • Tweet

There are 17,000 new hepatitis cases reported in the United States each year. If you are not familiar with hepatitis, hepatitis is an inflammation of the liver that is typically caused by a viral infection. In the United States, nearly 5 million Americans are living with Hepatitis, but 75% of those individuals are undiagnosed. Individuals can live with chronic hepatitis for decades without ever having symptoms.  We invite you to download our latest infographic to provide knowledge & clarity of the Hepatitis C epidemic in the United States.

Who is most at risk for contracting hepatitis C? 

  • Recipients of blood transfusions prior to 1992: Prior to June of 1992, most new cases of hepatitis C developed after individuals received blood transfusions. After June of 1992, a screening was put in place for hepatitis, which has helped to reduce the chances of contracting the hepatitis disease through blood transfusions.
  • IV drug users: 50% - 80% of new IV drug users become infected between 6 and 12 months after starting to use these drugs. The risk for these individuals is higher than most other individuals given their use of IV drugs.
  • Health care workers: Doctors, nurses, or laboratory professionals run a higher risk of contracting hepatitis C than the average individual. This is due to the regular exposure to blood products and accidental needle sticks, which increases their risk level for hepatitis c.
  • Dialysis patients: For these patients, hepatitis C can be transmitted through equipment that has not been properly disinfected, which increases their risk of contracting the disease.
  • Individuals with tattoos or piercings: Since equipment and supplies can technically be used on more than one individual, it is imperative to ensure that the equipment is sanitized and disinfected before receiving a tattoo or piercing. The same risk is also prevalent for something as common as manicures or pedicures.
  • Frequent contact with household individuals living with hepatitis: While the transmission rate is just 1% per year, it is important to note that spouses and individuals living in a household with a person infected with hepatitis C are at a slight risk as well. While the risk is much less, it is just something to keep in mind to ensure everyone’s safety in your home.

It is important to ensure you are taking all measures necessary when evaluating if you are at risk for hepatitis C. If you meet any of the above criteria, we suggest that you take this hepatitis risk assessment to determine if you are at risk for the disease. If you find that you may be at risk, we advise that you speak with your primary care physician to discuss next steps in the testing process.

Learn more about hepatitis C treatment and medications.

Take the Hepatitis  Risk Assessment

Topics Hepatitis

CONNECT WITH US

  • social-twitter
  • social-linkedin
  • social-youtube
  • social-facebook
  • social-yelp

Subscribe For Updates

Recent Posts

Posts by Topic

  • Avella (28)
  • Oncology (23)
  • Specialty Pharmacy (18)
  • Hepatitis (14)
  • Adherence (12)
  • HIV/AIDS (6)
  • Medication (6)
  • Cancer (5)
  • Fertility (5)
  • limited distribution drugs (4)
  • Accreditations (3)
  • Patients (3)
  • Public Health (3)
  • Addiction Management (2)
  • Pain Management (2)
  • mobile health (2)
  • 340b Program (1)
  • Complex Disease (1)
  • Dermatology (1)
  • IG Therapy (1)
  • In the News (1)
  • Inc (1)
  • Inc 5000 (1)
  • Industry News (1)
  • Infusion Therapy (1)
  • LLS (1)
  • Managed Care (1)
  • Partners (1)
  • Pharmacist (1)
  • Psoriasis (1)
  • RSV (1)
  • Rheumatoid Arthritis (1)
  • outsourcing facility (1)
  • payers (1)
see all
  • specialty_accreditation_seal-1
  • rsz_mail_service_accreditationseal
  • Addiction Management
  • Cardiovascular Disease
  • Dermatology
  • Fertility
  • Gastroenterology
  • Hepatitis
  • HIV / AIDS
  • Infusion Therapy
  • IG Therapy
  • Multiple Sclerosis
  • Oncology
  • Ophthalmology
  • Rheumatology
  • RSV
  • Transplant
  • Urology
  • Contact Avella
  • Terms of Use
  • Privacy
  • Blog
  • 877-546-5779
© 2025 Avella Specialty Pharmacy
  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
.